clinical trial · NCT06388642
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Clinuvel Europe Limited·phase2·completed·n = 28
Erythropoietic ProtoporphyriaAfamelanotide 16mg implant
brief summary
The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.
started
Mar 7, 2024
primary completion
Oct 28, 2024
completion
Jan 20, 2025
last updated
Mar 25, 2026
official title
A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients With Erythropoietic Protoporphyria (EPP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol